By InvitationNot Applicable

Enabling Microbiomics- Driven Personalized Nutrition

United States4,001 participantsStarted 2025-03-28

Plain-language summary

The goal of this observational research study is to determine how diet contributes to various gastrointestinal related conditions. The main question investigators aim to answer is: Are host genetics, diet, and microbiome all important determinants of GI disorders, and how their relative contribution varies among individuals and populations.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age greater than or equal to 18 years * Gastrointestinal patients with or without genomic sequencing results available for the following cohorts: * Inflammatory Bowel Disease (IBD) * Irritable Bowel Syndrome (IBS) * Crohn's Disease * Celiac Disease * Diarrhea * Constipation * Healthy age and sex matched controls with or without genomic sequencing results available o Control is defined as patients without gastrointestinal disease or no symptoms at time of sampling * Able to provide written, informed consent * Participant has a smartphone device with access to internet connection Exclusion Criteria: * Patients with cognitive impairment * Active use of antibiotics at the time of stool collection

What they're measuring

To Correlate Differences in Diet and Microbiome with Different GI Symptoms and Disease States

Timeframe: From enrollment through study completion, an average of 1 year.

Trial details

NCT IDNCT06657001

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09

View on ClinicalTrials.gov More Inflammatory Bowel Disease (IBD) trials